View in EDS HTML Full Text PDF Full Text

Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials.

Saved in:
Bibliographic Details
Title: Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials.
Authors: Armstrong AW; University of California Los Angeles, Los Angeles, California, USA., Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Sofen H; University of California Los Angeles, Los Angeles, California, USA.; Dermatology Research Associates, Los Angeles, California, USA., Morita A; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Paul C; Paul Sabatier University and CHU Larrey, Toulouse, France., Papp KA; Alliance Clinical Trials and Probity Medical Research, Waterloo, and the University of Toronto, Toronto, Ontario, Canada., Colombo MJ; Bristol Myers Squibb, Princeton, New Jersey, USA., Scotto J; Bristol Myers Squibb, Princeton, New Jersey, USA., Vaile J; Bristol Myers Squibb, Princeton, New Jersey, USA., Zhuo J; Bristol Myers Squibb, Princeton, New Jersey, USA., Vritzali E; Bristol Myers Squibb, Princeton, New Jersey, USA., Berger V; Bristol Myers Squibb, Princeton, New Jersey, USA., Schroeder G; Bristol Myers Squibb, Princeton, New Jersey, USA., Banerjee S; Bristol Myers Squibb, Princeton, New Jersey, USA., Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany., Strober B; Yale University School of Medicine, New Haven, and Central Connecticut Dermatology Research, Cromwell, Connecticut, USA.
Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2025 Jul; Vol. 39 (7), pp. 1336-1351. Date of Electronic Publication: 2025 Mar 06.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40045918
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Armstrong+AW%22">Armstrong AW</searchLink>; University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Lebwohl+M%22">Lebwohl M</searchLink>; Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Warren+RB%22">Warren RB</searchLink>; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Sofen+H%22">Sofen H</searchLink>; University of California Los Angeles, Los Angeles, California, USA.; Dermatology Research Associates, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Morita+A%22">Morita A</searchLink>; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Paul+C%22">Paul C</searchLink>; Paul Sabatier University and CHU Larrey, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Papp+KA%22">Papp KA</searchLink>; Alliance Clinical Trials and Probity Medical Research, Waterloo, and the University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Colombo+MJ%22">Colombo MJ</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Scotto+J%22">Scotto J</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Vaile+J%22">Vaile J</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Zhuo+J%22">Zhuo J</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Vritzali+E%22">Vritzali E</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Berger+V%22">Berger V</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Schroeder+G%22">Schroeder G</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Banerjee+S%22">Banerjee S</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Thaçi+D%22">Thaçi D</searchLink>; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Strober+B%22">Strober B</searchLink>; Yale University School of Medicine, New Haven, and Central Connecticut Dermatology Research, Cromwell, Connecticut, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229216037%22">Journal of the European Academy of Dermatology and Venereology : JEADV</searchLink> [J Eur Acad Dermatol Venereol] 2025 Jul; Vol. 39 (7), pp. 1336-1351. <i>Date of Electronic Publication: </i>2025 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9216037 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3083 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209269959%22">09269959 </searchLink><i>NLM ISO Abbreviation: </i>J Eur Acad Dermatol Venereol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40045918
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jdv.20553
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1336
    Titles:
      – TitleFull: Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Armstrong AW
      – PersonEntity:
          Name:
            NameFull: Lebwohl M
      – PersonEntity:
          Name:
            NameFull: Warren RB
      – PersonEntity:
          Name:
            NameFull: Sofen H
      – PersonEntity:
          Name:
            NameFull: Morita A
      – PersonEntity:
          Name:
            NameFull: Paul C
      – PersonEntity:
          Name:
            NameFull: Papp KA
      – PersonEntity:
          Name:
            NameFull: Colombo MJ
      – PersonEntity:
          Name:
            NameFull: Scotto J
      – PersonEntity:
          Name:
            NameFull: Vaile J
      – PersonEntity:
          Name:
            NameFull: Zhuo J
      – PersonEntity:
          Name:
            NameFull: Vritzali E
      – PersonEntity:
          Name:
            NameFull: Berger V
      – PersonEntity:
          Name:
            NameFull: Schroeder G
      – PersonEntity:
          Name:
            NameFull: Banerjee S
      – PersonEntity:
          Name:
            NameFull: Thaçi D
      – PersonEntity:
          Name:
            NameFull: Strober B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3083
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of the European Academy of Dermatology and Venereology : JEADV
              Type: main
ResultId 1